350 related articles for article (PubMed ID: 31974038)
1. Anti-TSLP antibodies: Targeting a master regulator of type 2 immune responses.
Nakajima S; Kabata H; Kabashima K; Asano K
Allergol Int; 2020 Apr; 69(2):197-203. PubMed ID: 31974038
[TBL] [Abstract][Full Text] [Related]
2. Thymic stromal lymphopoietin receptor blockade reduces allergic inflammation in a cynomolgus monkey model of asthma.
Cheng DT; Ma C; Niewoehner J; Dahl M; Tsai A; Zhang J; Gonsiorek W; Apparsundaram S; Pashine A; Ravindran P; Jung J; Hang J; Allard J; Bitter H; Tribouley C; Narula S; Wilson S; Fuentes ME
J Allergy Clin Immunol; 2013 Aug; 132(2):455-62. PubMed ID: 23810153
[TBL] [Abstract][Full Text] [Related]
3. Unmet need in severe, uncontrolled asthma: can anti-TSLP therapy with tezepelumab provide a valuable new treatment option?
Menzies-Gow A; Wechsler ME; Brightling CE
Respir Res; 2020 Oct; 21(1):268. PubMed ID: 33059715
[TBL] [Abstract][Full Text] [Related]
4. Expression and Regulation of Thymic Stromal Lymphopoietin and Thymic Stromal Lymphopoietin Receptor Heterocomplex in the Innate-Adaptive Immunity of Pediatric Asthma.
Lin SC; Cheng FY; Liu JJ; Ye YL
Int J Mol Sci; 2018 Apr; 19(4):. PubMed ID: 29670037
[TBL] [Abstract][Full Text] [Related]
5. Thymic Stromal Lymphopoietin and Tezepelumab in Airway Diseases: From Physiological Role to Target Therapy.
Bagnasco D; De Ferrari L; Bondi B; Candeliere MG; Mincarini M; Riccio AM; Braido F
Int J Mol Sci; 2024 May; 25(11):. PubMed ID: 38892164
[TBL] [Abstract][Full Text] [Related]
6. TSLP promotes interleukin-3-independent basophil haematopoiesis and type 2 inflammation.
Siracusa MC; Saenz SA; Hill DA; Kim BS; Headley MB; Doering TA; Wherry EJ; Jessup HK; Siegel LA; Kambayashi T; Dudek EC; Kubo M; Cianferoni A; Spergel JM; Ziegler SF; Comeau MR; Artis D
Nature; 2011 Aug; 477(7363):229-33. PubMed ID: 21841801
[TBL] [Abstract][Full Text] [Related]
7. Thymic stromal lymphopoietin and IL-33 modulate migration of hematopoietic progenitor cells in patients with allergic asthma.
Smith SG; Gugilla A; Mukherjee M; Merim K; Irshad A; Tang W; Kinoshita T; Watson B; Oliveria JP; Comeau M; O'Byrne PM; Gauvreau GM; Sehmi R
J Allergy Clin Immunol; 2015 Jun; 135(6):1594-602. PubMed ID: 25656998
[TBL] [Abstract][Full Text] [Related]
8. Early production of thymic stromal lymphopoietin precedes infiltration of dendritic cells expressing its receptor in allergen-induced late phase cutaneous responses in atopic subjects.
Corrigan CJ; Jayaratnam A; Wang Y; Liu Y; de Waal Malefyt R; Meng Q; Kay AB; Phipps S; Lee TH; Ying S
Allergy; 2009 Jul; 64(7):1014-22. PubMed ID: 19187393
[TBL] [Abstract][Full Text] [Related]
9. Tezepelumab: a novel biological therapy for the treatment of severe uncontrolled asthma.
Marone G; Spadaro G; Braile M; Poto R; Criscuolo G; Pahima H; Loffredo S; Levi-Schaffer F; Varricchi G
Expert Opin Investig Drugs; 2019 Nov; 28(11):931-940. PubMed ID: 31549891
[No Abstract] [Full Text] [Related]
10. Thymic stromal lymphopoietin receptor-mediated IL-6 and CC/CXC chemokines expression in human airway smooth muscle cells: role of MAPKs (ERK1/2, p38, and JNK) and STAT3 pathways.
Shan L; Redhu NS; Saleh A; Halayko AJ; Chakir J; Gounni AS
J Immunol; 2010 Jun; 184(12):7134-43. PubMed ID: 20483734
[TBL] [Abstract][Full Text] [Related]
11. Thymic stromal lymphopoietin activation of basophils in patients with allergic asthma is IL-3 dependent.
Salter BM; Oliveria JP; Nusca G; Smith SG; Watson RM; Comeau M; Sehmi R; Gauvreau GM
J Allergy Clin Immunol; 2015 Dec; 136(6):1636-1644. PubMed ID: 25962901
[TBL] [Abstract][Full Text] [Related]
12. Tezepelumab for asthma.
Nolasco S; Pelaia C; Scioscia G; Campisi R; Crimi C
Drugs Today (Barc); 2022 Dec; 58(12):591-603. PubMed ID: 36651067
[TBL] [Abstract][Full Text] [Related]
13. Thymic stromal lymphopoietin: a promising therapeutic target for allergic diseases.
Wang WL; Li HY; Zhang MS; Gao PS; He SH; Zheng T; Zhu Z; Zhou LF
Int Arch Allergy Immunol; 2013; 160(1):18-26. PubMed ID: 22948028
[TBL] [Abstract][Full Text] [Related]
14. TSLP Directly Interacts with Skin-Homing Th2 Cells Highly Expressing its Receptor to Enhance IL-4 Production in Atopic Dermatitis.
Tatsuno K; Fujiyama T; Yamaguchi H; Waki M; Tokura Y
J Invest Dermatol; 2015 Dec; 135(12):3017-3024. PubMed ID: 26288354
[TBL] [Abstract][Full Text] [Related]
15. Thymic stromal lymphopoietin signaling in CD4(+) T cells is required for TH2 memory.
Wang Q; Du J; Zhu J; Yang X; Zhou B
J Allergy Clin Immunol; 2015 Mar; 135(3):781-91.e3. PubMed ID: 25441291
[TBL] [Abstract][Full Text] [Related]
16. Thymic stromal lymphopoietin plays divergent roles in murine models of atopic and nonatopic airway inflammation.
Yadava K; Massacand J; Mosconi I; Nicod LP; Harris NL; Marsland BJ
Allergy; 2014 Oct; 69(10):1333-42. PubMed ID: 24961817
[TBL] [Abstract][Full Text] [Related]
17. Current summary of clinical studies on anti-TSLP antibody, Tezepelumab, in asthma.
Kurihara M; Kabata H; Irie M; Fukunaga K
Allergol Int; 2023 Jan; 72(1):24-30. PubMed ID: 36470789
[TBL] [Abstract][Full Text] [Related]
18. Structure and antagonism of the receptor complex mediated by human TSLP in allergy and asthma.
Verstraete K; Peelman F; Braun H; Lopez J; Van Rompaey D; Dansercoer A; Vandenberghe I; Pauwels K; Tavernier J; Lambrecht BN; Hammad H; De Winter H; Beyaert R; Lippens G; Savvides SN
Nat Commun; 2017 Apr; 8():14937. PubMed ID: 28368013
[TBL] [Abstract][Full Text] [Related]
19. The role of thymic stromal lymphopoietin in allergic inflammation and chronic obstructive pulmonary disease.
Fang C; Siew LQ; Corrigan CJ; Ying S
Arch Immunol Ther Exp (Warsz); 2010 Apr; 58(2):81-90. PubMed ID: 20143171
[TBL] [Abstract][Full Text] [Related]
20. ASP7266, a Novel Antibody against Human Thymic Stromal Lymphopoietin Receptor for the Treatment of Allergic Diseases.
Numazaki M; Abe M; Hanaoka K; Imamura E; Maeda M; Kimura A; Miyanohara J; Saito T; Arai K; Suzuki H; Saita Y
J Pharmacol Exp Ther; 2022 Jan; 380(1):26-33. PubMed ID: 34728559
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
